The following is a summary of “Recent advances and applications of optical coherence tomography angiography in diabetic ...

The research team noted that racial subgroups are underrepresented in clinical trials, a factor that should be addressed in ...

Now that figure has risen to more than 50,000 — and 25-30% of these patients have diabetic retinopathy, Dr. Provanzana said. Diabetic retinopathy is a diabetes-related eye disease that damages ...

Vantage Biosciences has dosed the first subject in the randomised Phase II trial of oral therapy VX-01 to treat ...

People with type 2 diabetes who regularly use the supplement glucosamine have a lower risk for microvascular complications ...

Diabetic Retinopathy is a progressive eye disease caused by damage to the blood vessels in the retina due to high blood sugar levels in diabetic patients. It is one of the leading causes of blindness ...

“We are pleased to initiate patient dosing in this important Phase 2 study, which evaluates VX-01 as a potential early intervention for diabetic retinopathy,” said Alek Safarian, Co-Founder ...